The Efficacy of AR101, a Peanut-Derived Pharmaceutical for Oral Immunotherapy (OIT), Is Maintained and Tolerability Is Increased with Low-Dose Maintenance Therapy
Link To: The Efficacy of AR101, a Peanut-Derived Pharmaceutical for Oral Immunotherapy (OIT), Is Maintained and Tolerability Is Increased with Low-Dose Maintenance Therapy
DOI: http://dx.doi.org/10.1016/j.jaci.2015.12.1265, Journal of Allergy and Clinical Immunology, Vol. 137, Issue 2, AB408, Published in issue: February 2016
http://www.jacionline.org/article/S0091-6749(15)03079-1/fulltext